Cristina Jiménez-Ortigosa

Dr. Cristina Jiménez-Ortigosa

Hackensack Meridian School of Medicine

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
CJCristina Jiménez-Ortigosa
Cristina Jiménez-Ortigosa
CMCaroline Moore
Caroline Moore
DDDavid W. Denning
David W. Denning
DPDavid S. Perlin
David S. Perlin
We have identified the first case of an fks1 hot spot 1 point mutation causing echinocandin resistance in a clinical Aspergillus fumigatus isolate recovered from a chronic pulmonary aspergillosis patient with an aspergilloma who first failed azole and polyene therapy and subsequently failed micafungin treatment.

21 August 2020 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
KHKelley Healey
Kelley Healey
PPPadmaja Paderu
Padmaja Paderu
XHXin Hou
Xin Hou
CJCristina Jiménez-Ortigosa
Cristina Jiménez-Ortigosa
NBNicole Bagley
Nicole Bagley
David PerlinDavid Perlin
David Perlin
Invasive infections caused by the opportunistic pathogen Candida glabrata are treated with echinocandin antifungals that target β-1,3-glucan synthase, an enzyme critical for fungal cell wall biosynthesis. Echinocandin resistance develops upon mutation of genes (FKS1 or FKS2) that encode the glucan synthase catalytic subunits. We have analyzed cellular factors that influence echinocandin susceptibility and here describe effects of the post-transcriptional regulator Ssd1, which in S. cerevisiae, can bind cell wall related gene transcripts. The SSD1 homolog in C. glabrata was disrupted in isogenic wild type and equivalent FKS1 and FKS2 mutant strains that demonstrate echinocandin resistance (MICs ˃ 0.5 µg/mL). A reversal of resistance (8- to 128-fold decrease in MICs) was observed in FKS1 mutants, but not in FKS2 mutants, following SSD1 deletion. Additionally, this phenotype was complemented upon expression of SSD1 from plasmid (pSSD1). All SSD1 disruptants displayed susceptibility to the calcineurin inhibitor FK506, similar to fks1∆. Decreases in relative gene expression ratios of FKS1 to FKS2 (2.6- to 4.5-fold) and in protein ratios of Fks1 to Fks2 (2.7- and 8.4-fold) were observed in FKS mutants upon SSD1 disruption. Additionally, a complementary increase in protein ratio was observed in the pSSD1 expressing strain. Overall, we describe a cellular factor that influences Fks1-specific mediated resistance and demonstrates further differential regulation of FKS1 and FKS2 in C. glabrata.

6 February 2021 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
CJCristina Jiménez-Ortigosa
Cristina Jiménez-Ortigosa
JJJennifer Jiang
Jennifer Jiang
MCMuyuan Chen
Muyuan Chen
Xuyuan KuangXuyuan Kuang
Xuyuan Kuang
KHKelley Healey
Kelley Healey
WDWei Dai
Wei Dai
Fungal plasma membrane proteins have long been recognized as targets for the development of antifungal agents. Despite recent progress in experimental approaches and computational structural predictions, our knowledge of the structural dynamics and spatial distribution of these membrane proteins in the context of their native lipid environment remains limited. By applying cryo-electron tomography (cryoET) and subtomogram analysis, we aim to characterize the structural characteristics and spatial distribution of membrane proteins present in Candida glabrata plasma membranes. This study has resulted in the identification of the membrane-embedded structure of the fungal H+-ATPase, Pma1. Tomograms of the plasma membrane revealed that Pma1 complexes are heterogeneously distributed as hexamers that cluster into distinct membrane microdomains. This study characterizes fungal membrane proteins in the native cellular landscape and highlights the unique potential of cryoET to advance our understanding of cellular biology and biological systems.

11 July 2021 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
Milena KordalewskaMilena Kordalewska
Milena Kordalewska
KGKevin D. Guerrero
Kevin D. Guerrero
RGRocio Garcia-Rubio
Rocio Garcia-Rubio
CJCristina Jiménez-Ortigosa
Cristina Jiménez-Ortigosa
JMJosé R. Mediavilla
José R. Mediavilla
David PerlinDavid Perlin
David Perlin
Fungal infections are common complications of respiratory viral infections and are associated with the increased need for intensive care and elevated mortality. Data regarding microbiological and molecular characteristics of such infections in COVID-19 patients are scarce. Here, we performed a comprehensive analysis, including species identification, antifungal susceptibility testing, molecular resistance determinants analysis, typing, and retrospective clinical data review, of fungal isolates recovered from 19 COVID-19 patients, who were hospitalized at the Hackensack University Medical Center (HUMC) in Hackensack, New Jersey, USA, in the initial phase of the pandemic from April–May 2020. In total, 17 Candida albicans, two C. parapsilosis, and two Aspergillus fumigatus were analyzed. All Candida spp. isolates were susceptible to micafungin and azole drugs (fluconazole, voriconazole, posaconazole, itraconazole, isavuconazole). A. fumigatus isolates were susceptible to micafungin and all triazole drugs except fluconazole (intrinsic resistance). Multilocus sequence typing (MLST) of C. albicans isolates revealed 15 different sequence types (STs), which clustered below the clade-defining limit of p-distance < 0.04. Pulsed-field gel electrophoresis (PFGE) karyotyping revealed no chromosomal rearrangements in these isolates. A. fumigatus isolates were of different, non-related genotypes. We speculate that virus- and drug-induced immunosuppression (94.7% of the patients received corticosteroids), together with prolonged hospital stay (median duration of 29 days) and mechanical ventilation (median duration of 24 days) likely increased the susceptibility to secondary respiratory and bloodstream infections in the studied patient population. The presence of fungi in blood or respiratory tract fluid was a prognosticator for poor clinical outcome, which presented as an 89.5% 30-day mortality in our patient cohort.

6 March 2024 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
CJCristina Jiménez-Ortigosa
Cristina Jiménez-Ortigosa
JJJennifer Jiang
Jennifer Jiang
MCMuyuan Chen
Muyuan Chen
Xuyuan KuangXuyuan Kuang
Xuyuan Kuang
KHKelley Healey
Kelley Healey
WDWei Dai
Wei Dai
The authors wish to update the article title to “Cryo-Electron Tomography of Candida glabrata Plasma Membrane Proteins”